← SynDRA
TROFOSFAMIDE
SynDRA canonical compound SYN0011619 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Mechanism of action | DNA alkylating agent |
| Indication | medulloblastoma |
| Disease area | oncology |
Mechanisms of action (all sources)
Drug classes
- Alkylating Agents
- Antineoplastic Agents
- Antineoplastic Agents, Alkylating
- Immunologic Factors
- Immunosuppressive Agents
- Mutagens
- Noxae
ATC classes
Cross-references
Synonyms
- ixoten
- trifosfamide
- trilofosfamida
- trilophosphamide
- triphosphamide
- trisfosfamide
- trofosfamid
- trophosphamid
- trophosphamide
- Trofosfamida
- A-4828
- NSC-109723
- Z-4828
- Trophosphamide
- Ixoten
- Trofosfamid
- Triphosphamide
- Trilofosfamida
- Trifosfamide
- Trisfosfamide
- Trilophosphamide
- Trofosfamidum
- Trofosfamide [INN]
- ASTA Z 4828
- Trofosfamida [Spanish]
- Trofosfamidum [INN-Latin]
- NSC 109723
- Trofosfamido [INN-Spanish]
- MLS002704177
- CCRIS 4442
- EINECS 244-770-8
- Trofosfamide (INN)
- BRN 0532530
- N,N,3-Tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
- N,N-3'-Tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine, 2-oxide
- H64JRU6GJ0
- NSC109723
- Genoxal Trofosfamida
Look up TROFOSFAMIDE in the interactive SynDRA portal →